A carregar...
Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety
Lacosamide (LCM) is a novel agent that has been developed as an antiepileptic drug. In vitro studies suggest that LCM modulates voltage-gated sodium channels by enhancing their slow inactivation. In addition, LCM seems to interact with collapsin-response mediator protein 2 and thus may mediate neuro...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2754090/ https://ncbi.nlm.nih.gov/pubmed/19816574 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|